Chengmei He

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Interstitial Lung Disease

Ejection Fraction

Systemic Sclerosis

Top Venues

International journal of rheumatic diseases

Therapeutic advances in chronic disease

Therapeutic advances in musculoskeletal disease

This page only lists publications with an associated author ORCID identifier.

Publications

Kunyu Zheng, Yiran Chen, Suying Liu, Chengmei He, Yunjiao Yang, Di Wu, Li Wang, Mengtao Li, Xiaofeng Zeng, Fengchun Zhang
Leflunomide: Traditional immunosuppressant with concurrent antiviral effects. International journal of rheumatic diseases (2022)
Chunlei Li, Kunyu Zheng, Yiran Chen, Chengmei He, Suying Liu, Yunjiao Yang, Meng Tao Li, Xiaofeng Zeng, Li Wang, Fengchun Zhang
A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid. Therapeutic advances in chronic disease 13 (2022)
Chengmei He, Yanlei Yang, Kunyu Zheng, Yiran Chen, Suying Liu, Yongzhe Li, Qin Han, Robert Chunhua Zhao, Li Wang, Fengchun Zhang
Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Therapeutic advances in chronic disease 12 (2021)
Junyan Qian, Chengmei He, Ya Li, Linyi Peng, Yunjiao Yang, Dong Xu, Yunyun Fei, Wen Zhang, Yan Zhao, Yi Dong, Yongzhe Li, Xuan Zhang, Hua Chen, Yanlei Yang, Zhilei Chen, Suying Liu, Li Wang, Fengchun Zhang
Ten-year survival analysis of patients with primary Sjögren's syndrome in China: a national prospective cohort study. Therapeutic advances in musculoskeletal disease 13 (2021)
Chengmei He, Zhilei Chen, Suying Liu, Hua Chen, Fengchun Zhang
Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: A systematic review and meta-analysis. International journal of rheumatic diseases 23 (8) (2020)